More NSPX about the CEO ... posted here so you can find it ... don't do Twitter at this time. Colin Hislop the new CEO via reverse merger, you know, the guy who helped to get CV Therapeutics sold to Gilead for $1.4 Billion. Want to know more about the new CEO? Boom: https://theorg.com/org/eiger-biopharmaceuticals/team/colin-hislop